Zhejiang Huakang Pharmaceutical Co., Ltd.

Equities

605077

CNE100005477

Food Processing

End-of-day quote Shanghai S.E. 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
23.93 CNY -1.20% Intraday chart for Zhejiang Huakang Pharmaceutical Co., Ltd. +13.04% +10.58%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Certain A Shares of Zhejiang Huakang Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024. CI
Zhoushan Huakang Biotechnology Co., Ltd. announced that it expects to receive CNY 700 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd. CI
Huakang Pharmaceutical Earmarks 248 Million Yuan for Corn Oil, Maltodextrin Plants MT
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhejiang Huakang Pharmaceutical Co., Ltd.(XSSC:605077) added to S&P Global BMI Index CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
HY Energy Plans to Sell Remaining Stake in Huakang Pharma CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhejiang Huakang Pharma Selling 1.3 Billion Yuan Convertible Bonds to Fund New Factory MT
Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077completed the acquisition of 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. CI
Zhejiang Huakang Pharma to Buy 95% of Thermal Power Firm for 522.5 Million Yuan MT
Zhejiang Huakang Pharmaceutical Co., Ltd. agreed to sign the Equity Transfer Agreement to acquire 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. for CNY 522.5 million. CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
HY Energy Plans to Unload Stake in Zhejiang Huakang Pharma CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Jiaozuo Huakang Sugar Alcohol Technology Co., Ltd. announced that it expects to receive CNY 295.8671 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd. CI
Ningbo Traditional Chinese Pharmaceutical Corp. announced that it has received CNY 21.97644 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd. CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Zhejiang Huakang Pharmaceutical Co., Ltd.(SHSE:605077) added to Shanghai Stock Exchange Composite Index CI
Zhejiang Huakang Pharmaceutical Co., Ltd.(SHSE:605077) added to Shanghai Stock Exchange A Share Index CI
Certain A Shares of Zhejiang Huakang Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2022. CI
Gaomi Tongli Sugar Co., Ltd. announced that it expects to receive CNY 20 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd. CI
Ningbo Traditional Chinese Pharmaceutical Corp. announced that it expects to receive CNY 21.97644 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd. CI
Chart Zhejiang Huakang Pharmaceutical Co., Ltd.
More charts
Zhejiang Huakang Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of a variety of functional sugar alcohols and starch sugar products. The Company's main products are xylitol, sorbitol, maltitol and grape syrup. Its products are mainly used in food, beverage, daily chemical and other fields. The Company conducts its businesses within the China market and to overseas markets such as Europe, America and Asia.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
23.93 CNY
Average target price
25 CNY
Spread / Average Target
+4.47%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 605077 Stock
  4. News Zhejiang Huakang Pharmaceutical Co., Ltd.
  5. Zhejiang Huakang Pharma to Buy 95% of Thermal Power Firm for 522.5 Million Yuan
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW